The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
Clinical trial NCT05238363 · UNKNOWN
Trial details
- NCT number
- NCT05238363
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2023-05-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.